A new industry body has been announced, charged with researching the surgical and non-surgical aesthetic treatments in order to improve the availability of data, which was highlighted as an issue by the Keogh review into safety and regulation of the sector earlier this year.
Sir Bruce Keogh who led the Government review said:
“I welcome the announcement from the Healing Foundation and BAAPS on the launch of the National Institute of Aesthetic Research. This joint initiative is the first recommendation of my review to be implemented and I know it will provide a major contribution to patient safety.”
The objective is ultimately to improve safety for patients who chose to have aesthetic or cosmetic procedures.
The British Association of Aesthetic Plastic Surgeons (BAAPS) have been campaigning for years to improve regulation of the botox and dermal fillers market. The latter in particular can still be sold without prescription and administered without training, exposing patients to unnecessary risk. BAAPs have even described fillers as the next scandal waiting to happen, after the PIP breast implant issues 2 years ago.
The NIAR are starting with the launch of the Breast Implant Safety Campaign, a programme of research into safety which will be funded at least in part by manufacturer donations.
Research into non-surgical treatments such as botox and dermal fillers will be the next priority.
Until new regulations come into force, patients are advised to choose their providers with care, by seeking an established company with a good reputation and a medical lead.
SkinViva in Manchester offer botox and dermal fillers across the North West and enjoy high patient satisfaction ratings. The Company was established over 5 years ago by Dr Tim Pearce and remains a medically led company with strong ethics and high standards. They have recently established their own training school to help other medical professionals learn the skills and techniques necessary to good practice.
For further information or to arrange a confidential consultation, please call 0161 865 1141, email email@example.com.